Tag Archive for: embera neurotherapeutics

Embera NeuroTherapeutics’ Chief Medical Officer, Michael Detke, to Moderate Panel on the Neuroscience of Addiction at BIO CEO & Investor Conference

Michael Detke, M.D., Ph.D., Embera’s Chief Medical Officer, will moderate the “Neuroscience of Addiction: Levers to Attack the Opioid Abuse Crisis” panel at 2018 BIO CEO & Investor Conference. The panel will be held on Tuesday, February 13, 2018, at 9 a.m. EST at the New York Marriott Marquis in New York City.